ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

Nutrition, Disease Oriented Contracts

December 4, 1981

NCAB Member Becker Says AACR ‘Feels Disenfranchised’

December 6, 1991

Clinical Education Program Phase Out Opposed By NCAB Committee

February 14, 1986

In Brief: NCCS to hold Candlelight Vigil Sept. 25; Moffit Wins Chemistry-Biology Grants

September 17, 1999

Relative Survival Now May be Over 50%, DeVita Says

December 3, 1982

ACCC To Consider Cancer Act Changes HSA Problems

January 7, 1977